|
Volumn 20, Issue 4, 2002, Pages 156-159
|
The legacy of nuclear risk and the founder effect in biotechnology organizations
|
Author keywords
[No Author keywords available]
|
Indexed keywords
HEALTH RISKS;
PUBLIC POLICY;
RISK ASSESSMENT;
BIOETHICS;
BIOTECHNOLOGY;
TOXIC GAS;
BIOTECHNOLOGY;
NUCLEAR ACCIDENT;
RISK ASSESSMENT;
BIOTECHNOLOGY;
CHERNOBYL ACCIDENT;
ENVIRONMENTAL MONITORING;
EXPLOSION;
HEALTH CARE POLICY;
HEALTH EDUCATION;
MEDICAL ETHICS;
NUCLEAR INDUSTRY;
NUCLEAR POWER PLANT;
NUCLEAR SAFETY;
PRIORITY JOURNAL;
PUBLIC HEALTH SERVICE;
PUBLIC RELATIONS;
REVIEW;
RISK ASSESSMENT;
RISK MANAGEMENT;
BIOTECHNOLOGY;
HUMANS;
POLICY MAKING;
POWER PLANTS;
PUBLIC OPINION;
PUBLIC POLICY;
RISK ASSESSMENT;
RISK MANAGEMENT;
SOCIETIES;
UNITED STATES;
|
EID: 0036532533
PISSN: 01677799
EISSN: None
Source Type: Journal
DOI: 10.1016/S0167-7799(01)01926-6 Document Type: Review |
Times cited : (6)
|
References (16)
|